Unió Europea -
estonià -
EMA (European Medicines Agency)
esbriet
roche registration gmbh - pirfenidone - idiopathic pulmonary fibrosis; lung diseases; respiratory tract diseases - immunosupressandid - esbriet is indicated in adults for the treatment of idiopathic pulmonary fibrosis.
Unió Europea -
estonià -
EMA (European Medicines Agency)
evkeeza
ultragenyx germany gmbh - evinacumab - hüperkolesteroleemia - lipiidi modifitseerivad ained - evkeeza is indicated as an adjunct to diet and other low-density lipoprotein-cholesterol (ldl-c) lowering therapies for the treatment of adult and adolescent patients aged 12 years and older with homozygous familial hypercholesterolaemia (hofh).
Estònia -
estonià -
Adama
legacy® 500 sc
adama - suspensioonikontsentraat - diflufenikaan - herbitsiidid
Estònia -
estonià -
Adama
mirador® 250 sc
adama - suspensioonikontsentraat - asoksüstrobiin - fungitsiidid
Estònia -
estonià -
Ravimiamet
pirfenidone teva õhukese polümeerikattega tablett
teva gmbh - pirfenidoon - õhukese polümeerikattega tablett - 801mg 252tk; 801mg 84tk
Estònia -
estonià -
Ravimiamet
pirfenidone teva õhukese polümeerikattega tablett
teva gmbh - pirfenidoon - õhukese polümeerikattega tablett - 267mg 252tk
Estònia -
estonià -
Ravimiamet
pirfenidone zentiva õhukese polümeerikattega tablett
zentiva k.s. - pirfenidoon - õhukese polümeerikattega tablett - 801mg 252tk
Unió Europea -
estonià -
EMA (European Medicines Agency)
pirfenidone axunio (previously pirfenidone aet)
axunio pharma gmbh - pirfenidone - idiopaatiline kopsufibroos - immunosupressandid - pirfenidone aet is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).
Unió Europea -
estonià -
EMA (European Medicines Agency)
pirfenidone viatris
viatris limited - pirfenidone - idiopathic pulmonary fibrosis; lung diseases; respiratory tract diseases - immunosupressandid - pirfenidone viatris is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).